Doctor

The non-invasive approach to the patient.

The treatment of AMD and many macular diseases, which can severely impair central vision, has undergone a revolution in the last decade due to the increasing use of intra-vitreal therapies.......

The correction of astigmatism is one of the most important goals of refractive cataract surgery today.
Dr. Scipione Rossi presents an overview of functional problems and technological solutions.

For a summary of the salient points, we provide the presentation. "TORICAL IOLS: functional problems and technological solutions" AICCER- Rome, 12 March 2016 Scipione Rossi Director UOC Ophthalmology......

Ever-increasing attention and research efforts.

Rare diseases are undoubtedly a major challenge for the health systems of all developed countries, even those with welfare and healthcare systems......

New steps in the training of young ophthalmologists

Phacoemulsification and intraocular lenses (IOLs) marked a revolution in cataract surgery several decades ago: in 1967 Charles D. Kelman performed the first phacoemulsification, while Harold......

Molecular editing to obtain biocompatible organs and tissues from animals.

The gap between the waiting lists of those in need of an organ and the number of organs actually available for transplantation is still very large and threatens to......

Promising results and limited side effects.

At the 33rd ASRS (American Society of Retina Specialists) Congress, Vienna 10-14 July 2015, data from a long-term study were presented, showing a good profile of......

Innovative technologies for cataract refractive surgery.
The development of new IOLs is in progress and some hi-tech IOLs are already undergoing clinical trials to strike the more and more challenging goals of contemporary cataract surgery.

The development of new IOLs is in progress and some hi-tech IOLs are already undergoing clinical trials to strike the more and more challenging goals of contemporary cataract surgery. The......

Size and location decisive in treatment outcome

Retinal haemangioblastoma is a rare disease that is difficult to manage, involving a careful assessment of the balance between potential visual loss caused by the tumour vs visual loss induced by therapeutic treatments. When......